UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
Proxy Statement Pursuant to Section 14(a)
of the
Securities Exchange Act of 1934 (Amendment
No. ___)
Filed
by the Registrant x
Filed
by a Party other than the Registrant ¨
Check
the appropriate box:
|
¨
|
Preliminary Proxy Statement
|
|
|
|
|
¨
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
|
|
x
|
Definitive Proxy Statement
|
|
|
|
|
¨
|
Definitive Additional Materials
|
|
|
|
|
¨
|
Soliciting Material Pursuant to Rule 14a-12
|
AMREP CORPORATION
(Name of Registrant as Specified In Its
Charter)
(Name of Person(s) Filing Proxy Statement,
if Other Than the Registrant)
Payment
of Filing Fee (Check the appropriate box):
|
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
|
|
|
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule
0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
¨
|
Fee paid previously with preliminary materials:
|
|
|
|
|
|
x
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify
the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or
the form or schedule and the date of its filing.
|
|
|
|
|
|
|
1)
|
Amount Previously Paid:
|
|
|
2)
|
Form, Schedule or Registration Statement No.:
|
AMREP CORPORATION
(An Oklahoma corporation)
NOTICE OF 2020 ANNUAL MEETING OF SHAREHOLDERS
September 10, 2020
NOTICE IS HEREBY GIVEN that the 2020 Annual
Meeting of Shareholders of AMREP Corporation (the “Company”) will be held at the Conference Center at 660 West Germantown
Pike, Plymouth Meeting, Pennsylvania 19462 on September 10, 2020 at 9:00 A.M. Eastern Time for the following purposes:
(1) To
elect two directors in Class III to hold office until the 2023 annual meeting of shareholders and until their successors are elected
and qualified;
(2) To
approve, on an advisory basis, the compensation paid to the Company’s named executive officers as disclosed in the accompanying
proxy statement;
(3) To
ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for fiscal year 2021;
and
(4) To
consider and act upon such other business as may properly come before the meeting.
In accordance with the Company’s
By-Laws, the Board of Directors has fixed the close of business on July 20, 2020 as the record date for the determination of shareholders
of the Company entitled to notice of and to vote at the meeting and any continuation or adjournment thereof. The list of such shareholders
will be available for inspection by shareholders during the ten days prior to the meeting at the offices of the Company, 620 West
Germantown Pike, Suite 175, Plymouth Meeting, Pennsylvania 19462.
Whether or not you expect to be present
at the meeting, please mark, date and sign the enclosed proxy card and return it to the Company in the self-addressed envelope
enclosed for that purpose. The proxy is revocable and will not affect your right to vote in person in the event you attend the
meeting.
The accompanying proxy statement is
dated July 31, 2020, and, together with the enclosed proxy card, is first being mailed to the shareholders of the Company on or
about July 31, 2020.
|
|
By Order of the Board of Directors
|
|
|
|
|
|
Christopher V. Vitale, President, Chief
Executive Officer and Secretary
|
|
Dated:
|
July 31, 2020
Plymouth Meeting, Pennsylvania
|
Important Notice Regarding the Availability
of Proxy Materials
for the Shareholder Meeting to be Held on September 10, 2020
The Proxy Statement and Annual Report
to Shareholders are available at http://www.edocumentview.com/axr.
Upon the written
request of any shareholder of the Company, the Company will provide to such shareholder a copy of the Company’s annual report
on Form 10-K for the year ended April 30, 2020, including the financial statements, filed with the Securities and Exchange Commission.
Any request should be directed to AMREP Corporation, 620 West Germantown Pike, Suite 175, Plymouth Meeting, Pennsylvania 19462,
Attention: Corporate Secretary. There will be no charge for such report unless one or more exhibits thereto are requested, in which
case the Company’s reasonable expenses of furnishing exhibits may be charged.
AMREP CORPORATION
620 West Germantown Pike, Suite 175
Plymouth Meeting, Pennsylvania 19462
PROXY STATEMENT
ANNUAL MEETING OF SHAREHOLDERS
To be Held at 9:00 A.M. Eastern Time on September 10, 2020
This proxy statement
(the “Proxy Statement”) is furnished in connection with the solicitation of proxies by the Board of Directors (the
“Board”) of AMREP Corporation (the “Company”) for use at the Annual Meeting of Shareholders of the Company
to be held on September 10, 2020, and at any continuation or adjournment thereof (the “Annual Meeting”). The Annual
Meeting will be held at the Conference Center at 660 West Germantown Pike, Plymouth Meeting, Pennsylvania 19462.
The Annual Report of
the Company on Form 10-K for the fiscal year ended April 30, 2020 filed on July 27, 2020 with the Securities and Exchange Commission
is included in this mailing but does not constitute a part of the proxy solicitation material. This Proxy Statement and the accompanying
Notice of 2020 Annual Meeting of Shareholders and proxy card are first being sent to shareholders on or about July 31, 2020. All
references in this Proxy Statement to fiscal 2020 and fiscal 2019 mean the Company’s fiscal years ended April 30, 2020 and
2019.
QUESTIONS AND ANSWERS CONCERNING THE
ANNUAL MEETING
What will be voted on at the Annual
Meeting?
There are three matters scheduled
for a vote:
|
|
·
|
Proposal Number 1: Election of two directors
in Class III to hold office until the 2023 annual meeting of shareholders and until their successors are elected and qualified;
|
|
|
·
|
Proposal Number 2: Approval, on an advisory
basis, of the compensation paid to the Company’s named executive officers as disclosed in this Proxy Statement; and
|
|
|
·
|
Proposal Number 3: Ratification of the
appointment of Marcum LLP as the Company’s independent registered public accounting firm for fiscal year 2021.
|
What if another matter is properly brought
before the Annual Meeting?
The Board knows of no other matters
that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the Annual Meeting,
it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment.
How does the Board recommend I vote
on the proposals?
The Board recommends that you
vote:
|
|
·
|
“For” the election as directors
of the two nominees named in this Proxy Statement;
|
|
|
·
|
“For” the approval, on an
advisory basis, of the compensation paid to the Company’s named executive officers as disclosed in this Proxy Statement;
and
|
|
|
·
|
“For” the ratification of
the appointment of Marcum LLP as the Company’s independent registered public accounting firm for fiscal year 2021.
|
Who is entitled to vote at the Annual
Meeting?
Only shareholders of record as
of the close of business on July 20, 2020, the date fixed by the Board in accordance with the Company’s By-Laws, are entitled
to notice of and to vote at the Annual Meeting.
If I have given a proxy, how do I revoke
that proxy?
Anyone giving a proxy may revoke
it at any time before it is exercised by giving the Secretary of the Company written notice of the revocation, by submitting a
proxy bearing a later date or by attending the Annual Meeting and voting.
How will my proxy be voted?
All properly executed, unrevoked
proxies in the enclosed form that are received in time will be voted in accordance with the shareholders’ directions and,
unless contrary directions are given, will be voted “For” the election as directors of the two nominees named in this
Proxy Statement, “For” the approval, on an advisory basis, of the compensation paid to the Company’s named executive
officers as disclosed in this Proxy Statement and “For” the ratification of the appointment of Marcum LLP as the Company’s
independent registered public accounting firm for fiscal year 2021 and, if any other matters are properly brought before the Annual
Meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best
judgment.
What if a nominee is unwilling or unable
to serve?
This is not expected to occur
but, in the event that it does, proxies will be voted for a substitute nominee designated by the Board or, in the discretion of
the Board, the position may be left vacant.
What are “broker non-votes”?
Under the rules that govern brokers,
if brokers or nominees who hold shares in “street name” on behalf of beneficial owners do not have instructions on
how to vote on matters deemed by the New York Stock Exchange to be “non-routine” (which include Proposal Numbers 1
and 2 in this Proxy Statement), a broker non-vote of those shares will occur, which means the shares will not be voted on such
matters. If your shares are held in “street name,” you must cast your vote or instruct your nominee or broker to do
so if you want your vote to be counted with respect to Proposal Numbers 1 and 2 in this Proxy Statement. Proposal Number 3
relating to the ratification of the appointment of Marcum LLP as the Company’s independent registered public accounting firm
for fiscal year 2021 is a matter on which brokers or nominees who hold shares in “street name” on behalf of beneficial
owners who have not been given specific voting instructions are allowed to vote such shares.
How are votes counted?
Votes will be counted by the
inspector of election appointed for the Annual Meeting, who will separately count votes as follows:
|
|
·
|
for Proposal Number 1
(for the election of directors), votes “For” and “Withhold” and broker non-votes;
|
|
|
·
|
for Proposal Number 2 (approval, on an advisory basis, of the compensation
paid to the Company’s named executive officers as disclosed in this Proxy Statement), votes “For”
and “Against,” abstentions and broker non-votes. Abstentions are treated as shares present and entitled to vote on
Proposal Number 2 and, therefore, will have the same effect as a vote “Against” Proposal Number 2;
|
|
|
·
|
for Proposal Number 3 (ratification
of the appointment of Marcum LLP as the Company’s independent registered public accounting firm for fiscal year 2021), votes
“For” and “Against,” abstentions and broker non-votes. Abstentions are treated as shares present and entitled
to vote on Proposal Number 3 and, therefore, will have the same effect as a vote “Against” Proposal Number 3.
|
Broker non-votes have no effect
and will not be counted towards the vote total for any proposal.
How many votes are needed to approve
each proposal?
|
|
·
|
With respect to Proposal Number 1 (for
the election of directors), the two nominees receiving the highest number of “FOR” votes from the holders of shares
present in person or represented by proxy and entitled to vote will be elected as directors. This is referred to as a plurality.
|
|
|
·
|
Proposal Number 2 (approval, on an advisory
basis, of the compensation paid to the Company’s named executive officers as disclosed in this Proxy Statement) must receive
“For” votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote
in order to be approved.
|
|
|
·
|
Proposal Number 3 (ratification of the
appointment of Marcum LLP as the Company’s independent registered public accounting firm for fiscal year 2021) must receive
“For” votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote
in order to be approved.
|
How many shares can be voted at the
Annual Meeting?
As of July 20, 2020, the Company
had issued and outstanding 8,141,904 shares of common stock, par value $.10 per share (“Common Stock”). Each share
of Common Stock is entitled to one vote on matters to come before the Annual Meeting.
How many votes will I be entitled to
cast at the Annual Meeting?
You will be entitled to cast
one vote for each share of Common Stock you held at the close of business on July 20, 2020, the record date for the Annual Meeting,
as shown on the list of shareholders at that date prepared by the Company’s transfer agent for the Common Stock.
What is the deadline for voting?
If you are a shareholder of record
and you choose to cause your shares to be voted by completing, signing, dating, and returning the enclosed proxy card, your proxy
card must be received before the Annual Meeting in order for your shares to be voted at the Annual Meeting.
If you hold your shares in street
name, please comply with the deadline for submitting voting instructions provided by the broker, bank or other nominee that holds
your shares.
What is a “quorum?”
The presence, in person or
by proxy, of the holders of a majority of the outstanding shares of Common Stock of the Company authorized to vote will
constitute a quorum for the transaction of business at the Annual Meeting. Abstentions will be counted in determining whether
a quorum is present at the Annual Meeting. Broker non-votes will be counted for purposes of calculating whether a quorum is
present at the Annual Meeting. A quorum must be present in order to transact business at the Annual Meeting.
Who may attend the Annual Meeting?
All shareholders of the Company
who owned shares of record at the close of business on July 20, 2020 may attend the Annual Meeting. If you want to vote in person
and you hold Common Stock in street name (i.e., your shares are held in the name of a broker, dealer, custodian bank or
other nominee), you must obtain a proxy card issued in your name from the firm that holds your shares and bring that proxy card
to the Annual Meeting, together with a copy of a statement from that firm reflecting your share ownership as of the record date,
and valid identification. If you hold your shares in street name and want to attend the Annual Meeting but not vote in person,
you must bring to the Annual Meeting a copy of a statement from the firm that holds your shares reflecting your share ownership
as of the record date and valid identification.
Where can I find the voting results
of the Annual Meeting?
Preliminary voting results will
be announced at the Annual Meeting. Final voting results will be tallied by the inspector of election after the taking of the vote
at the Annual Meeting. The Company will publish the final voting results in a Current Report on Form 8-K, which the Company is
required to file with the Securities and Exchange Commission.
COMMON STOCK OWNERSHIP OF
CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
Set forth in the following
table is information concerning the beneficial ownership, as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as
amended, of Common Stock by the persons who, to the knowledge of the Company, own beneficially more than 5% of the outstanding
shares. The table also sets forth the same information concerning beneficial ownership for each director of the Company, each named
executive officer of the Company, and all directors and named executive officers of the Company as a group. Unless otherwise indicated,
(i) reported ownership is as of July 20, 2020 and (ii) the Company understands that the beneficial owners have sole voting and
investment power with respect to the shares beneficially owned by them. In the case of directors and executive officers, the information
below has been provided by such persons at the request of the Company.
|
Name of Beneficial Owner
|
|
Shares of Common Stock
Beneficially Owned
|
|
|
Percent of
Class (%)
|
|
|
Nicholas G. Karabots, et al
|
|
|
2,096,061
|
(1)
|
|
|
25.7
|
%
|
|
Michael Melby, Gate City Capital Management, LLC
|
|
|
1,455,649
|
(2)
|
|
|
17.9
|
%
|
Albert V. Russo (Director),
Clifton Russo, Lawrence Russo,
Pasha Funding, LLC
|
|
|
1,286,278
|
(3)
|
|
|
15.8
|
%
|
|
Heinrich Bauer (USA) LLC
|
|
|
730,488
|
(4)
|
|
|
9.0
|
%
|
|
Robert E. Robotti (Director), et al
|
|
|
526,959
|
(5)
|
|
|
6.5
|
%
|
|
Other Directors and Named Executive Officers
|
|
|
|
|
|
|
|
|
|
Edward B. Cloues, II
|
|
|
20,499
|
(6)
|
|
|
*
|
|
|
Theodore J. Gaasche
|
|
|
20,094
|
(7)
|
|
|
*
|
|
|
Christopher V. Vitale
|
|
|
80,000
|
(8)
|
|
|
*
|
|
|
Adrienne M. Uleau
|
|
|
3,000
|
(9)
|
|
|
*
|
|
|
James M. McMonagle
|
|
|
3,500
|
|
|
|
*
|
|
|
Directors and Named Executive Officers as a Group (7 persons)
|
|
|
1,940,330
|
|
|
|
23.7
|
%
|
* Indicates
less than 1%.
|
|
(1)
|
The information in the table and in this footnote is based solely on Amendment No. 32 filed jointly
by these persons on September 12, 2016 to the Schedule 13D filed with the Securities and Exchange Commission on August 4,
1993. The following table sets forth information regarding the beneficial ownership of Common Stock by Mr. Karabots, Glendi Publications,
Inc. and Kappa Media Group, Inc., each of P.O. Box 736, Fort Washington, PA 19034.
|
|
Name of Beneficial Owner
|
|
Shares of Common Stock
Beneficially Owned
|
|
|
Nicholas G. Karabots
|
|
2,096,061
|
(a)
|
|
Glendi Publications, Inc.
|
|
967,544
|
(b)
|
|
Kappa Media Group, Inc.
|
|
1,026,517
|
(c)
|
|
|
(a)
|
Mr. Karabots has the sole power to vote or direct the vote, and the sole power to dispose or direct
the disposition, of such shares, of which 1,994,061 shares are owned indirectly through Glendi Publications, Inc. and Kappa Media
Group, Inc.
|
|
|
(b)
|
Mr. Karabots has the sole power to vote or direct the vote, and the sole power to dispose or direct
the disposition, of these shares, which are directly owned by Glendi Publications, Inc.
|
|
|
(c)
|
Mr. Karabots has the sole power to vote or direct the vote, and the sole power to dispose or direct
the disposition, of these shares, which are directly owned by Kappa Media Group, Inc.
|
|
(2)
|
The information in the table and this footnote is based solely on the Schedule 13D filed jointly
by these persons with the Securities and Exchange Commission on June 5, 2020. The principal address of Michael Melby and Gate City
Capital Management, LLC is 425 S. Financial Place, Suite 910A, Chicago, IL 60605. Michael Melby and Gate City Capital Management,
LLC have the sole power to vote or to direct the vote of 1,065,649 shares of Common Stock. Michael Melby and Gate City Capital
Management, LLC have the sole power to dispose or to direct the disposition of 1,455,649 shares of Common Stock.
|
|
(3)
|
Other than the number of deferred common share units owned by Mr. Albert V. Russo, the information
in the table and in this footnote is based solely on information received from Mr. Albert V. Russo. Albert V. Russo, Clifton Russo,
Lawrence Russo and Pasha Funding, LLC, each c/o Albert V. Russo, 401 Broadway, New York, NY 10013, have reported that they share
voting power as to 1,273,867 shares and that each of them has sole dispositive power as to the following numbers of such shares:
Albert V. Russo – 821,068; Clifton Russo – 237,617; Lawrence Russo – 181,442; and Pasha Funding, LLC –
33,740. Each of Albert V. Russo, Clifton Russo and Lawrence Russo owns one-third of the membership interests of Pasha Funding,
LLC. Mr. Albert V. Russo also owns 12,411 deferred common share units, where each deferred common share unit represents the right
to receive one share of Common Stock within 30 days after the first day of the month to follow Mr. Albert V. Russo’s
termination of service as a director of the Company.
|
|
(4)
|
The information in the table and this footnote is based solely on Amendment No. 1 filed by this
person with the Securities and Exchange Commission on February 4, 2020 to the Schedule 13G filed with the Securities and Exchange
Commission on June 24, 2014. The principal address of Heinrich Bauer (USA) LLC is 270 Sylvan Avenue, Englewood Cliffs, NJ 07632.
|
|
(5)
|
Other than the number of deferred common share units owned by Mr. Robotti, the information in the
table and in this footnote is based solely on information received from Mr. Robotti. The following table sets forth information
regarding the beneficial ownership of Common Stock by Robert E. Robotti, Robotti & Company, Incorporated (“R&CoI”),
Robotti Securities, LLC (“RS”) and Robotti & Company Advisors, LLC (“R&CoA”), each of 60 East 42nd
Street, Suite 3100, New York, NY 10165, and Kenneth R. Wasiak, Ravenswood Management Company, L.L.C. (“RMC”), The Ravenswood
Investment Company, L.P. (“RIC”) and Ravenswood Investments III, L.P. (“RI”), each of 104 Gloucester Road,
Massapequa, NY 11758.
|
|
Beneficial Owner
|
|
Shares Owned Beneficially
|
|
Robert E. Robotti
|
|
526,959
|
(a),(b),(c),(d),(e)
|
|
R&CoI
|
|
515,761
|
(a),(b)
|
|
RS
|
|
4,720
|
(a)
|
|
R&CoA
|
|
511,041
|
(b)
|
|
Kenneth R. Wasiak
|
|
284,753
|
(c),(d)
|
|
RMC
|
|
284,753
|
(c),(d)
|
|
RIC
|
|
155,550
|
(c)
|
|
RI
|
|
129,203
|
(d)
|
|
|
(a)
|
Each of Mr. Robotti and R&CoI share with RS the power to vote or direct the vote, and the power
to dispose or direct the disposition, of 4,720 shares of Common Stock owned by the discretionary customers of RS.
|
|
|
(b)
|
Each of Mr. Robotti and R&CoI share with R&CoA the power to vote or to direct the vote,
and the power to dispose or direct the disposition, of 511,041 shares of Common Stock owned by the advisory clients of R&CoA.
|
|
|
(c)
|
Each of RMC and Messrs. Robotti and Wasiak share with RIC the power to vote or direct the vote,
and the power to dispose or direct the disposition, of 155,550 shares of Common Stock owned by RIC.
|
|
|
(d)
|
Each of RMC and Messrs. Robotti and Wasiak share with RI the power to vote or to direct the vote,
and the power to dispose or direct the disposition, of 129,203 shares of Common Stock owned by RI.
|
|
|
(e)
|
Includes 11,198 deferred common share units issued to Mr. Robotti, where each deferred common share
unit represents the right to receive one share of Common Stock within 30 days after the first day of the month to follow Mr. Robotti’s
termination of service as a director of the Company.
|
|
|
(6)
|
Includes 12,411 deferred common share units, where each deferred common share unit represents the
right to receive one share of Common Stock within 30 days after the first day of the month to follow Mr. Cloues’ termination
of service as a director of the Company.
|
|
|
(7)
|
Includes 12,411 deferred common share units, where each deferred common share unit represents the
right to receive one share of Common Stock within 30 days after the first day of the month to follow Mr. Gaasche’s termination
of service as a director of the Company.
|
|
|
(8)
|
Includes 3,334 restricted shares of Common Stock that will vest on September 14, 2020, 15,000 restricted
shares of Common Stock that will vest on July 10, 2021, 2,500 restricted shares of Common Stock that will vest on July 11, 2021,
2,000 restricted shares of Common Stock that will vest on July 17, 2021, 2,500 restricted shares of Common Stock that will vest
on July 11, 2022, 2,000 restricted shares of Common Stock that will vest on July 17, 2022 and 2,000 restricted shares of Common
Stock that will vest on July 17, 2023, subject in each case to the continued employment of Mr. Vitale on each vesting date.
|
|
|
(9)
|
Includes 1,000 restricted shares of Common Stock that will vest on July 15, 2021, 1,000 restricted
shares of Common Stock that will vest on July 15, 2022 and 1,000 restricted shares of Common Stock that will vest on July 15, 2023,
subject in each case to the continued employment of Ms. Uleau on each vesting date.
|
PROPOSAL NUMBER 1
ELECTION OF DIRECTORS
The Board is a classified
board divided into three classes – Class I, Class II and Class III. Class I and II each consists of one director and Class
III consists of two directors. Each director serves for a term expiring at the annual meeting of shareholders held in the third
year following the year of his election and until his successor is elected and qualified. At this Annual Meeting, two Class III
directors will be elected to serve until the 2023 annual meeting of shareholders and until their successors are elected and qualified,
except in the event of any such director’s earlier death, resignation or removal. The terms of office of the Class I
and Class II directors will expire at the annual meetings of shareholders to be held in 2021 and 2022, respectively, upon
the election and qualification of their successors, except in the event of any such director’s earlier death, resignation
or removal.
At the recommendation
of its Nominating and Corporate Governance Committee, the Board is nominating Theodore J. Gaasche and Albert V. Russo, who are
the incumbent Class III directors, for reelection at the Annual Meeting. Although the Board does not expect that either of the
persons nominated will be unable to serve as a director, should either of them become unavailable it is intended that the shares
represented by proxies in the accompanying form will be voted for the election of a substitute nominee or nominees designated by
the Board or, in the discretion of the Board, the position or positions may be left vacant.
The Company believes
that its directors have the qualifications and skills necessary to serve as directors of the Company. The following information
relates to the nominees of the Board for election and the other directors of the Company.
Nominees to serve until the 2023
Annual Meeting of Shareholders (Class III):
THEODORE J. GAASCHE,
age 58, has been a director of the Company since 2013. Mr. Gaasche was a consultant for Spartan Organization, Inc., a private company
that advises various print, publishing and other portfolio companies, from February 2017 to October 2017 and during that period
served as a director of certain entities related to Spartan Organization, Inc. Mr. Gaasche was the Executive Vice President, Operations
of Spartan Organization, Inc. from 2013 to January 2017. Mr. Gaasche was the President and Chief Executive Officer of the Company
from 2011 to 2013. For over twenty years until 2008, Mr. Gaasche held positions of increasing responsibility at various
divisions of SunGard Data Systems Inc., most recently as the Chief Executive Officer of SunGard Availability Services, a division
of SunGard that provided disaster recovery, managed information technology and related services. Mr. Gaasche brings
to the Board his extensive business experience, including his knowledge of the Company as its prior President and Chief Executive
Officer.
ALBERT V. RUSSO,
age 66, has been a director of the Company since 1996. Mr. Russo is the Managing Partner of real estate entities 401
Broadway Building, Russo Associates and Pioneer Realty and has held these positions for more than the past five years. Mr.
Russo has been involved in the ownership and management of commercial real estate for more than 25 years and contributes to the
Board his specialized knowledge of the real estate business.
Director continuing in office until
the 2021 Annual Meeting of Shareholders (Class I):
EDWARD B. CLOUES,
II, age 72, has been a director of the Company since 1994 and currently serves as the Chairman of the Board. Mr. Cloues
has served as a director of Hillenbrand, Inc., a diversified global industrial company, since 2010. Mr. Cloues also serves as the
Vice Chairman of the Board of Trustees of Virtua Health, Inc., a non-profit hospital and healthcare system, where he chairs the
Finance and Investment Committee, is a member of the Compensation Committee and the Executive/Strategy Committee and is a member
and past Chairman of the Audit Committee. He served as Chairman of the Board of Penn Virginia Corporation, an oil and gas exploration
and development company, from 2011 to September 2016 and as the interim Chief Executive Officer of Penn Virginia Corporation from
October 2015 to September 2016 during the Board-led reorganization of that company, including a chapter 11 filing under the
U.S. Bankruptcy Code in May 2016 and the emergence from chapter 11 in September 2016 pursuant to a confirmed plan of reorganization.
He also served as a director (since 2003) and Chairman of the Board (since 2011) of PVR GP, LLC, the General Partner of PVR Partners,
L.P., a pipeline and natural resources master limited partnership, until its sale in 2014. Mr. Cloues was also a director,
the Chairman of the Board and the Chief Executive Officer of K-Tron International, Inc., a material handling equipment manufacturer,
from 1998 until its sale in 2010. Prior to 1998, Mr. Cloues was a law firm partner at a major global law firm where
he specialized in mergers and acquisitions and other business law matters. That law firm experience combined with the
experience gained from his former 12 year chief executive position with K-Tron International, Inc., which had been publicly held
prior to its sale, has given him a strong background in dealing with complex business transactions and general management issues. Additionally,
he brings to the Board a broad understanding of governance, audit and compensation issues as a result of his service on several
other public company boards.
Director continuing in office until
the 2022 Annual Meeting of Shareholders (Class II):
ROBERT E. ROBOTTI,
age 67, has been the president of Robotti & Company Advisors, LLC (a registered investment advisor) and Robotti Securities,
LLC, FKA Robotti & Company, LLC (a registered broker-dealer), and their predecessors, since 1983. He has been the managing
member of Ravenswood Management Company, LLC (and its predecessor) since 1980, which serves as the general partner of The Ravenswood
Investment Company, L.P. and Ravenswood Investments III, L.P. Mr. Robotti served as a portfolio manager of Robotti Global Fund,
LLC, a global equity fund, from 2007 to March 2015. Mr. Robotti has served as a director of PrairieSky Royalty Ltd., a petroleum
and natural gas royalty-focused company, since 2019. He also serves as a director and Chairman of the Board of Pulse Seismic Inc.,
a seismic data licensing business, and has held these positions for more than the past five years. Mr. Robotti was a director of
Panhandle Oil & Gas Company, a diversified mineral company, from 2004 to May 2020 and a director of BMC Building Materials
Holding Corporation from 2012 to December 2015. Mr. Robotti was a member of the SEC’s Advisory Committee of Smaller Public
Companies from 2005 to 2006 and also served on its corporate governance subcommittee. He has an MBA in Accounting and was a certified
public accountant earlier in his career, which license is currently inactive. Mr. Robotti’s qualifications to serve on the
Board include his extensive experience in the investment business as the founder, chief executive officer, chairman and controlling
owner of a registered investment advisor and a registered broker-dealer, and their predecessors, and as the manager of several
investment partnerships. Additionally, he brings to the Board a broad understanding of governance, audit and compensation issues
as a result of his service on several other public company boards.
THE BOARD UNANIMOUSLY
RECOMMENDS A VOTE “FOR” THE TWO CLASS III NOMINEES.
PROPOSAL NUMBER 2
ADVISORY VOTE ON THE COMPENSATION
PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS
Under the Dodd-Frank
Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) and Section 14A of the Securities Exchange
Act of 1934, as amended, the Company’s shareholders are entitled to vote to approve, on an advisory basis, the compensation
paid to the Company’s named executive officers as disclosed in this Proxy Statement in accordance with the rules of the Securities
and Exchange Commission. The compensation paid to the Company’s named executive officers subject to the vote is disclosed
in the compensation table and related narrative disclosure contained in this Proxy Statement.
The Board is asking
the shareholders to indicate their support for the compensation paid to the Company’s named executive officers as described
in this Proxy Statement by casting a non-binding advisory vote “For” the following resolution:
“RESOLVED, that the shareholders
of AMREP Corporation hereby APPROVE, on a nonbinding advisory basis, the compensation paid to the Company’s named executive
officers, as disclosed in the Company’s proxy statement for the 2020 Annual Meeting of Shareholders pursuant to the compensation
disclosure rules of the Securities and Exchange Commission, including the executive compensation table and narrative discussion
disclosed therein.”
Because the vote is
advisory, it is not binding on the Board or the Company. In accordance with the Dodd-Frank Act, the vote to approve the compensation
of the Company’s named executive officers shall not be construed: (i) as overruling any decision by the Company or the Board;
(ii) to create or imply any change in the fiduciary duties of the Company or the Board; or (iii) to create or imply any additional
fiduciary duties for the Company or the Board. Nevertheless, the views expressed by the shareholders, whether through this vote
or otherwise, are important to management and the Board and, accordingly, the Board and the Compensation and Human Resources Committee
intend to consider the results of this vote in making determinations in the future regarding executive compensation arrangements.
At the most
recent annual meeting of shareholders held on September 12, 2019, the Company’s shareholders voted to approve, on an
advisory basis, the compensation paid to the Company’s named executive officers as disclosed in the proxy statement for
that meeting dated August 2, 2019. Nevertheless, the Company did receive a significant number of votes against approving this
compensation, primarily from the Company’s largest beneficial shareholder. The Chairman of the Compensation and Human
Resources Committee reached out to this shareholder to receive feedback and better understand the reasons for the negative
vote. In response, the shareholder’s expressed reasons for the negative vote were his belief that the amounts paid to
the Company’s named executive officers were in excess of the amounts he believed appropriate, including his belief that
the issuance of restricted shares of Common Stock should not be a component of executive compensation, and his general
dissatisfaction with the overall direction of the Company and its overhead cost structure. With respect to these objections,
the Company notes that it had only three named executive officers in fiscal 2019, that their fiscal 2019 annual salaries
ranged from $197,000 to $318,000, that no bonus was paid to any named executive officers except for one $10,000 bonus and
that an aggregate of 29,200 restricted shares of Common Stock were issued to the Company’s named executive
officers in fiscal 2019.
Advisory approval of
this proposal requires the affirmative vote of the holders of a majority of the shares present in person or represented by
proxy and entitled to vote at the Annual Meeting.
THE BOARD UNANIMOUSLY
RECOMMENDS A VOTE “FOR” THE APPROVAL OF THE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS AS DISCLOSED
IN THIS PROXY STATEMENT.
PROPOSAL NUMBER 3
RATIFICATION OF APPOINTMENT OF THE INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
The Audit Committee
of the Board of Directors of the Company has appointed the firm of Marcum LLP, certified public accountants, as the independent
registered public accounting firm to make an examination of the consolidated financial statements of the Company for its fiscal
year ending April 30, 2021, and the Board of Directors and the Audit Committee recommend that the shareholders ratify this appointment.
Marcum LLP served as the independent registered public accounting firm of the Company for the fiscal year ended April 30, 2020.
A representative of Marcum LLP is expected to be present at the Annual Meeting with the opportunity to make a statement if he or
she desires to do so and to be available to respond to appropriate questions.
While shareholder ratification
of the appointment of the Company’s independent registered public accounting firm is not required, the Company values the
opinions of its shareholders and believes that shareholder ratification of the appointment of the Company’s independent registered
public accounting firm is a good corporate governance practice. If a majority of the votes cast at the Annual Meeting are against
ratification of Marcum LLP, the Audit Committee will reconsider whether to retain Marcum LLP and may retain that firm or another
firm without resubmitting the matter to the Company’s shareholders. If the shareholders fail to ratify the selection, the
Audit Committee will seek to understand the reasons that the shareholders did not ratify its selection of Marcum LLP. The Audit
Committee will be under no obligation, however, to select a new independent auditor. Even if the appointment is ratified, the Audit
Committee may, in its discretion, direct the appointment of a different independent auditor at any time during the year if it determines
that such change would be in the Company’s best interests and in the best interests of the Company’s shareholders.
Audit Fees
The following table
sets forth certain information concerning the fees of Marcum LLP for fiscal years 2020 and 2019. The reported fees, except the
Audit Fees, are amounts billed to the Company in the indicated fiscal years. The Audit Fees are for services for those fiscal years.
|
|
|
Fiscal Year Ended April 30,
|
|
|
|
|
2020
|
|
|
2019
|
|
|
Audit Fees(1)
|
|
$
|
142,192
|
|
|
$
|
166,216
|
|
|
Audit-Related Fees(2)
|
|
|
2,575
|
|
|
|
21,775
|
|
|
Tax Fees(3)
|
|
|
-
|
|
|
|
-
|
|
|
All Other Fees
|
|
|
-
|
|
|
|
-
|
|
|
Total
|
|
$
|
144,767
|
|
|
$
|
187,991
|
|
|
|
(1)
|
Consists of fees for the audit annual financial statements included in the Company’s annual
report on Form 10-K and reviews of the unaudited financial statements included in the Company’s quarterly reports on Form
10-Q.
|
|
|
(2)
|
Consists of fees for the audits of employee benefit plans.
|
|
|
(3)
|
Includes fees for tax compliance, tax advice and tax planning.
|
Pre-Approval Policies and Procedures
The Audit Committee
pre-approves all audit services to be provided by the independent registered public accounting firm and, separately, all permitted
non-audit services to be performed by the independent registered public accounting firm.
THE BOARD UNANIMOUSLY
RECOMMENDS A VOTE “FOR” RATIFICATION OF THE APPOINTMENT OF MARCUM LLP AS THE COMPANY’S INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR 2021.
THE BOARD OF DIRECTORS AND ITS COMMITTEES
Governance Standards
The Company’s
Common Stock is listed on the New York Stock Exchange, and the Company is subject to the New York Stock Exchange’s Corporate
Governance Standards (the “Governance Standards”). The Governance Standards, among other things, generally require
a listed company to have independent directors within the meaning of the Governance Standards as a majority of its board of directors
and for the board to have a nominating/corporate governance committee, an audit committee and a compensation committee, each composed
entirely of independent directors.
Based principally on
their responses to questions to these persons regarding the relationships addressed by the Governance Standards and discussions
with them, the Board has determined that other than his service as a director, each of Edward B. Cloues, II, Theodore J. Gaasche,
Robert E. Robotti and Albert V. Russo has no material relationship with the Company, either directly or as a partner, shareholder
or officer of an organization that has a relationship with the Company, and, therefore, meets the director independence requirements
of the Governance Standards.
As
required by the Governance Standards, the Board has adopted Corporate Governance Guidelines (the “Guidelines”) that
address various matters involving the Board and the conduct of its business. The Board has also adopted a Code of Business Conduct
and Ethics setting forth principles of business conduct applicable to the directors, officers and employees of the Company. The
Guidelines and Code of Business Conduct and Ethics, as well as the charters of the Board’s Nominating and Corporate Governance
Committee, Audit Committee and Compensation and Human Resources Committee, may be viewed under “Corporate Governance”
on the Company’s website at www.amrepcorp.com, and written copies will be provided to any shareholder upon written
request to the Company at AMREP Corporation, 620 West Germantown Pike, Suite 175, Plymouth Meeting, Pennsylvania 19462, Attention:
Corporate Secretary. The Company intends to disclose on its website any amendment to or waiver of any provision of the Code of
Business Conduct and Ethics that applies to its principal executive officer, principal financial officer, principal accounting
officer or controller or persons performing similar functions. The Company’s Insider Trading Policy, which applies to all
employees and directors, includes, among other provisions, a prohibition of any hedging or monetization transactions involving
the Company’s securities.
Directors
are expected to attend Annual Meetings of Shareholders, and all of the directors attended last year’s Annual Meeting. The
Board held six meetings during the last fiscal year. All of the directors attended all of the meetings held during the last fiscal
year of the Board and its Committees of which they were members. Pursuant to the Guidelines, the Board has established a policy
that the non-management directors meet in executive session at least twice per year and that the independent directors also meet
in executive session at least twice per year. The Chairman of the Board (currently, Edward B. Cloues, II), if in attendance, will
be the presiding director at each such executive session; otherwise, those attending may select a presiding director.
Any
shareholder or other interested person wishing to communicate with the Board or any of the directors may send a letter addressed
to the member or members of the Board to whom the communication is directed in care of AMREP Corporation, 620 West Germantown Pike,
Suite 175, Plymouth Meeting, Pennsylvania 19462, Attention: Corporate Secretary. All such communications will be forwarded to the
specified addressee(s).
Nominating and Corporate Governance
Committee
The Board has a Nominating
and Corporate Governance Committee that operates under a written charter adopted by the Board. Each member of the Nominating and
Corporate Governance Committee is required to be an independent director, as defined by the Governance Standards. The members of
this Committee are Messrs. Cloues (Chairman), Robotti and Russo, each of whom has been determined by the Board to be an independent
director within the meaning of the Governance Standards. This Committee reports regularly to the Board concerning its activities.
The Nominating and Corporate Governance Committee held three meetings during the last fiscal year.
The duties of the Nominating
and Corporate Governance Committee include identifying individuals the Committee considers qualified to be elected Board members
consistent with criteria approved by the Board, and recommending persons to be nominated by the Board for election by the shareholders.
When considering a nominee for election as a director, the Committee considers the experience, skills and knowledge of business
and management practices a candidate may possess and the perspective he or she may bring to the Board, and employs criteria calling
for, among other things, personal and professional integrity, good judgment, a high level of ability and business acumen, and experience
in the Company’s industries, as well as the ability of the nominee to devote sufficient time to performing his or her duties
on the Board in an effective manner. Although the Committee has no specific policy regarding the diversity of the membership of
the Board, it is the objective of the Committee that the Board be comprised of persons of diverse backgrounds such that as a unit
the members of the Board will possess the necessary skills to appropriately discharge their responsibilities as the Company’s
directors. The Committee is also responsible for periodically reviewing and recommending changes to the Guidelines and for overseeing
the Company’s corporate governance practices.
The Nominating and
Corporate Governance Committee will consider candidates for director recommended by shareholders on the same basis as any other
proposed nominees. Any shareholder desiring to propose a candidate for selection as a nominee of the Board for election at the
2021 Annual Meeting of Shareholders may do so by sending a written communication no later than May 1, 2021 to the Nominating and
Corporate Governance Committee, AMREP Corporation, 620 West Germantown Pike, Suite 175, Plymouth Meeting, Pennsylvania 19462, Attention:
Corporate Secretary, identifying the proposing shareholder, specifying the number of shares of Common Stock held by such shareholder
and stating the name and address of the proposed nominee and the information concerning such person that the regulations of the
Securities and Exchange Commission require be included in a proxy statement relating to such person’s proposed election as
a director.
Audit Committee
The Board has an Audit
Committee that operates under a written charter adopted by the Board. Each member of the Audit Committee is required to be an independent
director, as defined by the Governance Standards. The members of this Committee are Messrs. Cloues (Chairman), Robotti and Russo,
each of whom has been determined by the Board to be an independent director within the meaning of the Governance Standards. The
Board has also determined that Mr. Robotti qualifies as an audit committee financial expert within the meaning of Securities and
Exchange Commission regulations. This Committee reports regularly to the Board concerning its activities. The Audit Committee held
five meetings during the last fiscal year.
The duties of the
Audit Committee include (i) appointing the Company’s independent registered public accounting firm, approving the
services to be provided by that firm and its compensation and reviewing that firm’s independence and performance of
services, (ii) reviewing the scope and results of the yearly audit by the independent registered public accounting firm,
(iii) reviewing the Company’s system of internal controls and procedures, (iv) reviewing with management and the
independent registered public accounting firm the Company’s annual and quarterly financial statements, (v) reviewing
the Company’s financial reporting and accounting standards and principles and (vi) overseeing the administration and
enforcement of the Company’s Code of Business Conduct and Ethics. In addition to the Audit Committee’s
responsibilities set forth above, the Audit Committee has, pursuant to its charter, primary responsibility for the oversight
of risks that could affect the Company.
Compensation and Human Resources Committee
The Board has a Compensation
and Human Resources Committee that operates under a written charter adopted by the Board. Each member of the Compensation and Human
Resources Committee is required to be an independent director, as defined by the Governance Standards. The members of this Committee
are Messrs. Robotti (Chairman), Cloues and Russo, each of whom has been determined by the Board to be an independent director within
the meaning of the Governance Standards. This Committee reports regularly to the Board concerning its activities. During the last
fiscal year, the Compensation and Human Resources Committee held two meetings.
The Compensation and
Human Resources Committee is responsible for reviewing and approving corporate goals and objectives applicable to the Company’s
chief executive officer and determining his compensation and that of the Company’s other executive officers and making recommendations
to the Board concerning other matters relating to executive officer and director compensation. With respect to salaries, bonuses
and other compensation and benefits, the decisions and recommendations of the Compensation and Human Resources Committee are subjective
and are not based on any list of specific criteria. In the past, factors influencing the Committee’s decisions regarding
executive salaries have included the Committee’s assessment of the executive’s performance and any changes in functional
responsibility. In determining the salary to be paid to a particular individual, the Committee applies these and other criteria,
while also using its best judgment of compensation applicable to other executives holding comparable positions both within the
Company and at other companies. Executive officers of the Company do not play a role in determining their compensation. Neither
the Board nor the Committee has engaged compensation consultants for the purposes of determining or advising upon executive or
director compensation.
Risk Oversight
The Board is
actively involved in risk oversight and management of risk. The Board has ultimate responsibility for the oversight of risks
facing the Company and for the management of those risks, including overseeing cybersecurity and other information technology
security matters, with the Audit Committee conducting preliminary evaluations of risk and addressing risk prior to review by
the Board. The Audit Committee considers and reviews with management the Company’s internal control processes. The
Audit Committee also considers and reviews with the Company’s independent registered public accounting firm the
adequacy of the Company’s internal controls, including the processes for identifying significant risks or exposures,
and elicits recommendations for the improvement of such procedures where needed. In addition to the Audit Committee’s
role, the full Board is involved in the oversight and administration of risk and risk management practices by overseeing
members of senior management in their risk management capacities. Members of the Company’s senior management have
day-to-day responsibility for risk management and establishing risk management practices, and members of management are
expected to report matters relating specifically to the Audit Committee directly thereto, and to report all other matters
directly to the Chairman of the Board or the Board as a whole. Members of the Company’s senior management have an open
line of communication to the Chairman of the Board and the Board as a whole and have the discretion to raise issues from
time-to-time in any manner they deem appropriate, and management’s reporting on issues relating to risk management
typically occurs through direct communication with directors, the Chairman of the Board or the Audit Committee as matters
requiring attention arise.
In furtherance of its
risk oversight responsibilities, the Board has evaluated the Company’s overall compensation policies and practices for its
employees to determine whether such policies and practices create incentives that could reasonably be expected to affect the risks
faced by the Company and its management, has further assessed whether any risks arising from these policies and practices are reasonably
likely to have a material adverse effect on the Company, and has concluded that the risks arising from the Company’s policies
and practices are not reasonably likely to have a material adverse effect on the Company.
No Material Proceedings
As of July 31, 2020,
there are no material proceedings to which any director, executive officer or affiliate of the Company or any owner of more than
five percent of the Common Stock, or any associate of any of the foregoing, (i) is a party adverse to the Company or any of
its subsidiaries or (ii) has a material interest adverse to the Company or any of its subsidiaries.
EXECUTIVE OFFICERS
For information with
respect to executive officers, see “Information about our Executive Officers” in Part I of the Company’s Annual
Report on Form 10-K for the year ended April 30, 2020, filed pursuant to the Securities Exchange Act of 1934, as amended.
COMPENSATION OF EXECUTIVE OFFICERS
The following table
contains summary information regarding the compensation of the Company’s executive officers as required by Item 402(n) of
Regulation S-K.
Summary Compensation Table
|
Name
and Principal Position
|
|
Year(1)
|
|
|
Salary
($)
|
|
|
Bonus
($)
|
|
|
Stock
Awards(2) ($)
|
|
|
All
Other Compensation(3)
($)
|
|
|
Total
($)
|
|
CHRISTOPHER V.
VITALE
President and Chief Executive Officer of the Company
|
|
|
2020
2019
|
|
|
|
325,000
318,269
|
|
|
|
60,000-
|
|
|
|
47,588
176,250
|
|
|
|
3,705
322
|
|
|
|
436,293
494,841
|
|
ADRIENNE M. ULEAU(4)
Vice President, Finance and Accounting of the Company
|
|
|
2020
|
|
|
|
112,642
|
|
|
|
11,000
|
|
|
|
-
|
|
|
|
1,450
|
|
|
|
125,092
|
|
JAMES M. MCMONAGLE(5)
Former Vice President and Chief Financial Officer of the Company
|
|
|
2020
2019
|
|
|
|
185,231
197,308
|
|
|
|
15,000-
|
|
|
|
9,518
10,575
|
|
|
|
9,743
409
|
|
|
|
219,492
208,292
|
|
|
|
(1)
|
The year references are to the fiscal years ended April
30.
|
|
|
(2)
|
The amounts indicated represent the grant date fair value related to awards of restricted stock
granted during fiscal 2020 and fiscal 2019 computed in accordance with stock-based accounting rules (Financial Accounting
Standards Board Accounting Standards Codification Topic 718). The determination of this value is based on the methodology set forth
in Note 11 to the Company’s audited
financial statements included in the Company’s Annual Report on Form 10-K for the year ended April 30, 2020.
|
|
|
(3)
|
The amounts reported include payment of life insurance, matching contributions to the Company’s
Simple IRA plan and, in the case of Mr. McMonagle, severance.
|
|
|
(4)
|
Ms. Uleau was appointed Vice President, Finance and Accounting of the Company effective as of March
17, 2020.
|
|
|
(5)
|
Mr. McMonagle ceased employment with the Company effective as of March 17, 2020.
|
Outstanding Equity Awards at April 30,
2020
|
|
|
Stock Awards
|
|
|
Name
|
|
Equity Incentive Plan Awards:
Number of Unearned Shares,
Units or Other Rights that
have not Vested
(#)
|
|
|
Equity Incentive Plan Awards:
Market or Payout Value of Unearned
Shares, Units or other Rights that have
not Vested
($)(1)
|
|
|
CHRISTOPHER V. VITALE
|
|
|
32,834
|
(2)
|
|
$
|
158,917
|
|
|
ADRIENNE M. ULEAU
|
|
|
-
|
|
|
|
-
|
|
|
JAMES M. MCMONAGLE
|
|
|
-
|
|
|
|
-
|
|
|
|
(1)
|
Value is based on the closing price per share of Common Stock of $4.84 on April 30, 2020, as reported
on the New York Stock Exchange.
|
|
|
(2)
|
2,000 restricted shares of Common Stock that will vest on June 21, 2020, 5,000 restricted shares
of Common Stock that will vest on July 10, 2020, 2,500 restricted shares of Common Stock that will vest on July 11, 2020, 3,334
restricted shares of Common Stock that will vest on September 14, 2020, 15,000 restricted shares of Common Stock that will vest
on July 10, 2021, 2,500 restricted shares of Common Stock that will vest on July 11, 2021 and 2,500 restricted shares of Common
Stock that will vest on July 11, 2022, subject in each case to the continued employment of Mr. Vitale on each vesting date.
|
On July 15, 2020, the Company awarded Ms.
Uleau a $15,000 cash bonus and 3,000 restricted shares of Common Stock of the Company that vests one-third on July 15, 2021, one-third
on July 15, 2022 and one-third on July 15, 2023, subject to the continued employment of Ms. Uleau on each vesting date. On July
17, 2020, the Company awarded Mr. Vitale a $60,000 cash bonus and 6,000 restricted shares of Common Stock of the Company that vests
one-third on July 17, 2021, one-third on July 17, 2022 and one-third on July 17, 2023, subject to the continued employment of Mr.
Vitale on each vesting date.
Other than as
described below, the Company’s executive officers are not subject to agreements or other arrangements that provide for
payments upon a change in control of the Company and the Company’s policies for severance payments upon termination of
employment apply to the executive officers on the same basis as the Company’s other salaried employees. The
Compensation and Human Resources Committee retains the discretion to enter into severance agreements with individual
executive officers on terms satisfactory to it. Under the terms of the
AMREP Corporation 2006 Equity Compensation Plan, its administrator has the discretion to accelerate the vesting of, or
otherwise remove restrictions on, awards under the AMREP Corporation 2006 Equity Compensation Plan upon a change in control
of the Company. The AMREP Corporation 2006 Equity Compensation Plan expired by its terms on September 19, 2016. Under the
terms of the AMREP Corporation 2016 Equity Compensation Plan and subject to the provisions of the applicable award agreement,
restrictions on certain awards under the AMREP Corporation 2016 Equity Compensation Plan shall automatically lapse upon a
change in control of the Company.
COMPENSATION OF DIRECTORS
Compensation for the
non-employee members of the Board is approved by the Board, which considers recommendations for director compensation from the
Company’s Compensation and Human Resources Committee.
For the period ending
June 30, 2019, compensation provided to the non-employee members of the Board was as follows:
|
|
·
|
Each non-employee member of the Board
was paid an annual cash fee of $60,000 in equal quarterly installments.
|
|
|
·
|
On the last trading day of each calendar
year, each non-employee member of the Board was to be issued the number of deferred common share units of the Company under the
AMREP Corporation 2016 Equity Compensation Plan equal to $20,000 divided by the closing price per share of Common Stock reported
on the New York Stock Exchange on such date.
|
|
|
·
|
The Chairmen of the Audit Committee and
of the Compensation and Human Resources Committee were each paid an annual fee of $7,500 in equal quarterly installments, and the
other members of those committees were not paid any fee with respect to service on such committees. The members of the Nominating
and Corporate Governance Committee, including its Chairman, served without additional compensation.
|
|
|
·
|
In addition to the fees described above,
Edward B. Cloues, II was paid an annual fee of $135,000 for his services as Chairman of the Board in equal monthly installments.
|
|
|
·
|
There were no separate meetings fees for
the Board or any committee thereof.
|
Effective July 1, 2019,
compensation provided to the non-employee members of the Board is as follows:
|
|
·
|
Each non-employee member of the Board
is paid an annual cash fee of $30,000 in equal quarterly installments.
|
|
|
·
|
On the last trading day of calendar year
2019, each non-employee member of the Board will be issued the number of deferred common share units of the Company under the AMREP
Corporation 2016 Equity Compensation Plan equal to $25,000 divided by the closing price per share of Common Stock reported on the
New York Stock Exchange on such date.
|
|
|
·
|
On the last trading day of each calendar
year after calendar year 2019, each non-employee member of the Board will be issued the number of deferred common share units of
the Company under the AMREP Corporation 2016 Equity Compensation Plan equal to $30,000 divided by the closing price per share of
Common Stock reported on the New York Stock Exchange on such date.
|
|
|
·
|
The Chairman of the Audit Committee is
paid an annual fee of $7,500 in equal quarterly installments. The Chairman of the Compensation and Human Resources Committee is
paid an annual fee of $3,750 in equal quarterly installments. Other members of the Audit Committee and the Compensation and Human
Resources Committee are not paid any fee with respect to service on such committees. The members of the Nominating and Corporate
Governance Committee, including its Chairman, serve without additional compensation.
|
|
|
·
|
In addition to the fees described above,
Edward B. Cloues, II is paid an annual fee of $95,000 for his services as Chairman of the Board in equal monthly installments.
|
|
|
·
|
All amounts are pro-rated to reflect any
director’s removal or retirement from the Board, any decision that a director not stand for reelection to the Board or any
new director being appointed or elected to the Board; provided that, any deferred common share units of the Company that would
have been issued on the last trading day of a calendar year to a director who ceased to be a director prior to such issuance date
shall be paid in cash rather than as deferred common share units of the Company, where the cash payment will equal the number of
shares underlying the pro rata number of deferred common share units that would have been issued to the director multiplied by
the closing price per share of Common Stock reported on the New York Stock Exchange on the last trading day of the calendar year.
|
|
|
·
|
There are no separate meetings fees for
the Board or any committee thereof.
|
The Board believes
that significant stock ownership by Board members further aligns their interests with the interests of the Company’s shareholders.
Accordingly, each current non-employee director is expected to own at least 30,000 shares of Common Stock of the Company by July
1, 2022 and to maintain such ownership thereafter. Newly elected non-employee directors would be expected to meet this level of
ownership within five years of their election to the Board and to maintain such ownership thereafter. Non-employee members of the
Board may satisfy the ownership guidelines with Common Stock in these categories: shares owned directly or indirectly and time-vested
restricted stock, deferred stock units or restricted stock units. The Board may modify this policy in its discretion.
The following table
summarizes the compensation earned by the Company’s directors for fiscal 2020:
|
Name
|
|
Fees Earned or Paid
in Cash
($)
|
|
|
Stock Awards
($)(1)(2)
|
|
|
Total
($)
|
|
|
Edward B. Cloues, II
|
|
$
|
144,170
|
|
|
|
25,000
|
|
|
|
169,170
|
|
|
Theodore J. Gaasche
|
|
|
35,000
|
|
|
|
25,000
|
|
|
|
60,000
|
|
|
Robert E. Robotti
|
|
|
39,375
|
|
|
|
25,000
|
|
|
|
64,375
|
|
|
Albert V. Russo
|
|
|
35,000
|
|
|
|
25,000
|
|
|
|
60,000
|
|
|
|
(1)
|
The amounts indicated represent the grant date fair value related to awards of deferred common
share units during fiscal 2020 computed in accordance with stock-based accounting rules (Financial Accounting
Standards Board Accounting Standards Codification Topic 718). The determination of this value is based on the methodology set forth
in Note 11 to the Company’s audited financial statements included in the Company’s Annual Report on Form 10-K for the
year ended April 30, 2020.
|
|
|
(2)
|
The following table sets forth the number of deferred common share units issued to each director
on the last trading day of calendar year 2019 and the total number of deferred common share units outstanding with respect to each
director (where each deferred common share unit represents the right to receive one share of Common Stock within 30 days after
the first day of the month to follow such director’s termination of service as a director of the Company).
|
|
Name
|
|
Deferred Common Share Units
Issued
on the Last Trading Day of Calendar
Year 2019
|
|
Total Outstanding
Deferred Common
Share Units
|
|
Edward B. Cloues, II
|
|
4,180
|
|
12,411
|
|
Theodore J. Gaasche
|
|
4,180
|
|
12,411
|
|
Robert E. Robotti
|
|
4,180
|
|
11,198
|
|
Albert V. Russo
|
|
4,180
|
|
12,411
|
EQUITY COMPENSATION PLAN INFORMATION
The following table
sets forth information as of April 30, 2020 concerning Common Stock of the Company that is issuable under its compensation plans.
|
Plan Category
|
|
(A)
Number of
securities to be
issued upon exercise
of outstanding
options, warrants
and rights
|
|
|
(B)
Weighted average
exercise price of
outstanding
options, warrants
and rights
|
|
|
(C)
Number of securities
remaining available for
future issuance under
equity compensation
plans (excluding
securities reflected in
column (A))
|
|
|
Equity compensation plans approved by shareholders
|
|
|
48,431(1)
|
|
|
|
-
|
|
|
|
440,050(2)
|
|
|
Equity compensation plans not approved by shareholders
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Total
|
|
|
48,431
|
|
|
|
-
|
|
|
|
440,050
|
|
|
|
(1)
|
Represents the number of deferred common share units issued to each director pursuant to the AMREP
Corporation 2016 Equity Compensation Plan (where each deferred common share unit represents the right to receive one share of Common
Stock within 30 days after the first day of the month to follow such director’s termination of service as a director of the
Company).
|
|
|
(2)
|
Represents shares of Common Stock available for grant under the AMREP Corporation 2016 Equity Compensation
Plan less outstanding grants previously made under the plan, but does not reflect any reduction for the number of shares of Common
Stock to be issued pursuant to the deferred common share units described in Column A.
|
CERTAIN TRANSACTIONS
Prior to the sale by
the Company on April 26, 2019 of Palm Coast Data LLC and certain other indirect subsidiaries of the Company, the Company provided
subscription fulfillment services for a company owned or controlled by Nicholas G. Karabots, a significant shareholder of the Company,
pursuant to a contract determined, by a committee of directors found to be independent of Mr. Karabots, to be fair and reasonable
and no less favorable to the Company than would be obtained in an arm’s length transaction with a non-affiliate having a
volume of business with the Company comparable to that of Mr. Karabots. The Company’s revenue from the subscription fulfillment
services it provided to Mr. Karabots’ company was approximately $132,900 for fiscal 2019.
COMPENSATION COMMITTEE INTERLOCKS AND
INSIDER PARTICIPATION
During fiscal 2020,
there were no interlocking relationships between the Company’s Board of Directors or Compensation and Human Resources Committee,
or the board of directors or compensation committee of any other company that are required to be disclosed under Item 407 of Regulation
S-K.
DELINQUENT SECTION 16(a) REPORTS
Section 16(a) of the
Securities Exchange Act of 1934, as amended, requires the Company’s directors, officers and holders of more than 10% of its
Common Stock to file initial reports of ownership and reports of changes of ownership of the Common Stock with the Securities and
Exchange Commission and the New York Stock Exchange. Based solely on a review of the copies of the reports received by the Company
and certain written representations from the directors and executive officers, the Company believes that for fiscal 2020, all required
Section 16(a) reports were filed on a timely basis, except that Ms. Uleau, who became the Company’s principal financial officer
on March 17, 2020, filed a Form 3 on April 17, 2020 reporting that she did not beneficially own any securities of the Company and
that Gate City Capital Management, LLC filed a Form 3 on June 15, 2020 reporting that it beneficially owns 1,455,649 shares of
Common Stock. With respect to the delinquent filing for Gate City Capital Management, LLC, (1) the Company does not know the total
number of late reports or the total number of transactions that were not reported on a timely basis and (2) based on a review of
the Schedule 13D filed by Gate City Capital Management, LLC with the Securities and Exchange Commission on June 5, 2020, Gate City
Capital Management, LLC had six transactions between April 7, 2020 and May 29, 2020 that were not reported on a timely basis.
AUDIT-RELATED MATTERS
The consolidated financial
statements of the Company and its subsidiaries included in the Company’s Annual Report on Form 10-K for the year ended April
30, 2020 have been audited by Marcum LLP, an independent registered public accounting firm.
Audit Committee Report
The Audit
Committee has reviewed and discussed the Company’s audited financial statements for fiscal 2020 with management, which
has primary responsibility for the financial statements. Marcum LLP, as the Company’s independent registered public
accounting firm for fiscal 2020, is responsible for expressing an opinion on the conformity of the Company’s audited
financial statements with U.S. generally accepted accounting principles. The Audit Committee has discussed with Marcum LLP
the matters that are required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board
and the Securities and Exchange Commission. Marcum LLP has provided to the Audit Committee the written disclosures and the
letter required by the Public Company Accounting Oversight Board regarding the independent registered public accounting
firm’s communications with the Audit Committee concerning independence, and the Audit Committee has discussed with
Marcum LLP that firm’s independence. Based on these considerations, the Audit Committee has recommended to the Board
that the financial statements audited by Marcum LLP be included in the Company’s Annual Report on Form 10-K for fiscal
2020 for filing with the Securities and Exchange Commission.
The foregoing report
is provided by the following directors who constitute the Audit Committee:
|
|
Edward B. Cloues, II, Chairman
|
|
|
Robert E. Robotti
|
|
|
Albert V. Russo
|
Dated: July 15, 2020
OTHER MATTERS
The Board knows of
no matters that will be presented for consideration at the Annual Meeting other than the matters referred to in this Proxy Statement.
Should any other matters properly come before the Annual Meeting, it is the intention of the persons named in the accompanying
proxy to vote such proxy in accordance with their best judgment.
SOLICITATION OF PROXIES
The Company will bear
the cost of this solicitation of proxies. In addition to solicitation of proxies by mail, the Company may reimburse brokers and
other nominees for the expense of forwarding proxy materials to the beneficial owners of Common Stock held in their names. Directors,
officers and employees of the Company may solicit proxies on behalf of the Board but will not receive any additional compensation
therefor.
SHAREHOLDER PROPOSALS
From time to time,
shareholders present proposals that may be proper subjects for inclusion in the Proxy Statement and for consideration at an annual
meeting. Shareholders who intend to present proposals at the 2021 Annual Meeting of Shareholders and who wish to have such proposals
included in the Company’s Proxy Statement for the 2021 Annual Meeting of Shareholders must be certain that such proposals
are received by the Company’s Secretary at the Company’s executive offices, 620 West Germantown Pike, Suite 175, Plymouth
Meeting, Pennsylvania 19462, not later than April 2, 2021. Such proposals must meet the requirements set forth in the rules and
regulations of the Securities and Exchange Commission in order to be eligible for inclusion in the Proxy Statement. For any proposal
that is not submitted for inclusion in next year’s Proxy Statement but is, instead, sought to be presented directly at the
2021 Annual Meeting of Shareholders, Securities and Exchange Commission rules permit management to vote proxies in its discretion
if the Company does not receive notice of the proposal prior to the close of business on June 16, 2021.
HOUSEHOLDING OF PROXY MATERIALS
The Securities and
Exchange Commission has adopted rules that permit companies and intermediaries to satisfy delivery requirements for proxy statements
and annual reports to shareholders and, if applicable, notices of Internet availability of proxy materials, with respect to two
or more shareholders sharing the same address by delivering a single copy of the material addressed to those shareholders. This
process, commonly referred to as “householding,” is designed to reduce duplicate printing and postage costs. The Company
and some brokers may household notices of Internet availability of proxy materials, annual reports to shareholders and proxy materials,
by delivering a single copy of the material to multiple shareholders sharing the same address unless contrary instructions have
been received from the affected shareholders.
If a shareholder wishes
to receive a separate notice of Internet availability of proxy materials, the annual report to shareholders or proxy statement,
or if a shareholder received multiple copies of some or all of these materials and would prefer to receive a single copy in the
future, the shareholder should submit a request by phone or in writing to the shareholder’s broker if the shares are held
in a brokerage account or, if the shares are registered in the name of the shareholder, to the Company’s transfer agent,
Computershare Investor Services, P.O. Box 505008, Louisville, Kentucky 40233-9814, (800) 368-5948.
|
|
By
Order of the Board of Directors
|
|
|
|
|
|
Christopher
V. Vitale, Secretary
|
|
|
|
|
Dated:
July 31, 2020
|
|
AMREP (NYSE:AXR)
Historical Stock Chart
From Mar 2024 to Apr 2024
AMREP (NYSE:AXR)
Historical Stock Chart
From Apr 2023 to Apr 2024
